PAHC up +5.51% percent right now. $PAHC High is at 28.99

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 2:50 PM

PAHC up +5.51% percent right now. $PAHC High is at 28.99 and the Low 26.57 with current volume of 116,800.

Recent News posted below.

PAHC Phibro Animal Health Corp Recent Headline News

Netflix and Gilead Will See More Gains, Says Thornburg Value Manager
at The Street - Thu Oct 30, 4:54PM CDT
Gilead shares have had a tremendous run this year, but the valuation remains cheap considering its sales potential in the area of Hepatitis C.
NFLX: 384.16 (+0.86), PAHC: 28.34 (+1.48), GILD: 106.45 (-0.49)

Weakness Seen in Trinity Biotech (TRIB): Stock Tumbles 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:44AM CDT
Shares of Trinity Biotech fell nearly 8% last session and witnessed flat revision in current year estimates in the past few weeks suggest a close watch of the firm in the near future.
ZLTQ: 27.49 (-0.25), PAHC: 28.34 (+1.48), GWPH: 73.97 (-0.41), TRIB: 17.43 (-0.42)

Can the Uptrend Continue for Phibro Animal Health (PAHC)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 8:29AM CDT
Can the Uptrend Continue for Phibro Animal Health (PAHC)?
PAHC: 28.34 (+1.48)

Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2014 Quarterly Financial Results
GlobeNewswire - Fri Oct 10, 1:04PM CDT
Phibro Animal Health Corporation (Nasdaq

AHC) will host a webcast and conference call to review first quarter financial results. A news release containing quarterly results is expected to be issued after the market closes on November 11, 2014.
PAHC: 28.34 (+1.48)

Dairy: The Future Of Protein - Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts
M2 - Mon Oct 06, 9:25AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w9wq33/dairy_the) has announced the addition of the "Dairy: The Future Of Protein - Global Markets, Competitors And Opportunities - 2014-2019 Analysis And Forecasts" report to their offering. The long-term thesis supporting the market for protein is hard to ignore: more people equals more mouths to feed, while the shift in diets, notably among emerging markets, will drive increased demand for protein of all types. This implies a substantial revenue opportunity for those facilitating the procurement, trading, storage, and transportation of protein products. This report focuses on Dairy protein only, whose production is estimated at USD354.4 billion in 2014, and is forecast to grow more than 10% annually over the next five years. Topics covered in the report include global protein production by class and type, dairy production by type and region, dairy retail sales, exports, imports, foreign markets, the feed outlook, alfalfa production, yogurt demand and the Chinese infant milk formula market, among others. The report contains detailed analysis of the major dairy market players in terms of their product offerings, markets served, strategies, competitors and financial performance. In addition to profiles of 34 public companies involved in the dairy industry, the report also contains 78 tables and 125 figures. Key Topics Covered: 1. Introduction 2. Executive Summary 3. Protein Overview 4. Protein Market Overview 5. Dairy Protein Market Companies Mentioned: - AGCO Corporation - Archer Daniels Midland Company - Balchem Corporation - Beingmate Baby & Child Food - Biostime International - Bunge Limited - China Mengniu Dairy Company Limited - China Modern Dairy Holdings - Chr. Hansen Holding - Dairy Crest Group - Danone - Dean Foods Company - Deere & Company - Dupont E I De Nemours & Co - Emmi - Farmland Partners Inc. - Fonterra Co-operative Group Limited - General Mills - Glanbia plc - Gloria SA - Kraft Foods Group - Mead Johnson Nutrition Company - Megmilk Snow Brand - Meiji Holdings - Monsanto - Morinaga Milk Industry - Nestle SA - Phibro Animal Health - Ridley Inc.. - S&W Seed Company - Syngenta - Synlait Milk Limited - Synutra International - Yakult Honsha - Yili Group For more information visit http://www.researchandmarkets.com/research/w9wq33/dairy_the
KRFTV: 44.10 (-0.53), SANW: 3.08 (+0.01), PAHC: 28.34 (+1.48), FPI: 10.59 (-0.05), AGCO: 45.55 (+0.91), SYUT: 6.48 (+0.01), BCPC: 63.99 (+0.45), BG: 88.76 (+0.31), MJN: 98.39 (-0.45), ADM: 50.55 (+0.58), DE: 88.66 (+0.89), DF: 14.42 (+0.16), GIS: 51.36 (-1.91)

The Zacks Analyst Blog Highlights: Super Micro Computer, Horizon Pharma, Phibro Animal Health, Seattle Genetics and Takeda Pharmaceutical
PR Newswire - Thu Oct 02, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Super Micro Computer, Inc. (Nasdaq:SMCI-Free Report), Horizon Pharma plc (Nasdaq:HZNP-Free Report), Phibro Animal Health Corp. (Nasdaq

AHC-Free Report), Seattle Genetics, Inc. (Nasdaq:SGEN-Free Report) and Takeda Pharmaceutical Company Ltd. (OTC:TKPYY-Free Report).
SMCI: 33.93 (+1.03), SGEN: 36.05 (+1.20), PAHC: 28.34 (+1.48), HZNP: 12.99 (-0.27)

3 Best Performing Stocks in September - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Oct 01, 3:01PM CDT
International headwinds dragged down the markets in September as all the benchmarks took losses over the month.
SMCI: 33.93 (+1.03), PAHC: 28.34 (+1.48), HZNP: 12.99 (-0.27)

Phibro Animal Health Corporation Reports Fourth Quarter and Annual Results
GlobeNewswire - Tue Sep 16, 4:26PM CDT
Phibro Animal Health Corporation (Nasdaq

AHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2014. It also provided guidance for its fiscal year ending June 30, 2015.
PAHC: 28.34 (+1.48)

Phibro Animal Health Corporation to Participate in Morgan Stanley's 2014 Global Healthcare Unplugged Conference
GlobeNewswire - Wed Aug 13, 4:30PM CDT
Phibro Animal Health Corporation (Nasdaq

AHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Morgan Stanley 2014 Global Healthcare Unplugged Conference.
PAHC: 28.34 (+1.48), MS: 35.66 (+0.35)

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2014 Results
GlobeNewswire - Fri Aug 08, 3:00PM CDT
Phibro Animal Health Corporation (Nasdaq

AHC) will host a webcast and conference call to review fourth quarter and fiscal year 2014 financial results, discuss fiscal year 2015 financial guidance and respond to questions from investors. A news release containing quarterly and fiscal year results is expected to be issued after the market closes on September 16, 2014.
PAHC: 28.34 (+1.48)

Phibro Animal Health Corporation Declares Quarterly Dividend
GlobeNewswire - Mon Jul 28, 3:15PM CDT
The Board of Directors of Phibro Animal Health Corporation (Nasdaq

AHC), today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 24, 2014, to stockholders of record at the close of business on September 3, 2014.
PAHC: 28.34 (+1.48)

Will Fiscal 2015 Growth Plans Help in Campbell's Turnaround? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 22, 5:00PM CDT
Campbell Soup Company (CPB) revealed its growth plans for fiscal 2015 as well as the actions that are being taken to revive its business.
PAHC: 28.34 (+1.48), THS: 80.16 (-5.33), CPB: 44.10 (-0.59), PF: 33.57 (-0.23)

SUPERVALU (SVU) Jumps: Stock Rises 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 17, 8:04AM CDT
SUPERVALU Inc. (SVU) was a big mover last session, as the company saw its shares rise over 7% on the day.
PAHC: 28.34 (+1.48), SVU: 8.62 (+0.09), THS: 80.16 (-5.33), BRFS: 25.41 (+0.17)

Diamond Foods to Grow on Turnaround Strategies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 4:35PM CDT
On Jul 3, 2014, we issued an updated research report on Diamond Foods (DMND).
HAIN: 107.68 (-0.16), DMND: 29.68 (-0.33), PAHC: 28.34 (+1.48), THS: 80.16 (-5.33)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Davos Healthcare Aims to Revolutionize Hospital Ratings

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Cracking the Code of America's Delivery Addiction

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

AI-Driven Lumi Transforms Car Dealership Interactions

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Anecdotes by Artists Brings Raw Scent Stories to Sephora

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

FutureVault's AI Agents: Transforming Financial Workflows

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

FJBio Boosts Antibody Discovery with Sapio AI

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...